Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

NCT03569007 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

307

Enrollment

INDUSTRY

Sponsor class

Stopped Trial terminated by Sponsor

Conditions

Celiac Disease

Interventions

DRUG: Larazotide
DRUG: Matching Placebo

Sponsor

9 Meters Biopharma, Inc.